Literature DB >> 18974103

A history of cancer chemotherapy.

Vincent T DeVita1, Edward Chu.   

Abstract

The use of chemotherapy to treat cancer began at the start of the 20th century with attempts to narrow the universe of chemicals that might affect the disease by developing methods to screen chemicals using transplantable tumors in rodents. It was, however, four World War II-related programs, and the effects of drugs that evolved from them, that provided the impetus to establish in 1955 the national drug development effort known as the Cancer Chemotherapy National Service Center. The ability of combination chemotherapy to cure acute childhood leukemia and advanced Hodgkin's disease in the 1960s and early 1970s overcame the prevailing pessimism about the ability of drugs to cure advanced cancers, facilitated the study of adjuvant chemotherapy, and helped foster the national cancer program. Today, chemotherapy has changed as important molecular abnormalities are being used to screen for potential new drugs as well as for targeted treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974103     DOI: 10.1158/0008-5472.CAN-07-6611

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  349 in total

1.  Dying of hematologic patients--treatment characteristics in a German University Hospital.

Authors:  Patrick Brück; Malgorzata Pierzchlewska; Marta Kaluzna-Oleksy; Maria Elizabeth Ramos Lopez; Mathias Rummel; Dieter Hoelzer; Angelika Böhme
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

Review 2.  Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.

Authors:  Angelo Guainazzi; Orlando D Schärer
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

Review 3.  Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

Authors:  Sophie Marchal; Amélie El Hor; Marie Millard; Véronique Gillon; Lina Bezdetnaya
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

4.  Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy.

Authors:  R Ganugula; M Deng; M Arora; H-L Pan; M N V Ravi Kumar
Journal:  ACS Chem Neurosci       Date:  2019-01-17       Impact factor: 4.418

Review 5.  Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer.

Authors:  Himashinie V K Diyabalanage; Michael L Granda; Jacob M Hooker
Journal:  Cancer Lett       Date:  2012-09-29       Impact factor: 8.679

Review 6.  Cancer stem cells: relevance to SCT.

Authors:  T Lin; R J Jones; W Matsui
Journal:  Bone Marrow Transplant       Date:  2009-02-23       Impact factor: 5.483

Review 7.  A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drug.

Authors:  David Rey Arpon; Maher K Gandhi; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

Review 8.  Concepts in Cancer Modeling: A Brief History.

Authors:  Renee M Thomas; Terry Van Dyke; Glenn Merlino; Chi-Ping Day
Journal:  Cancer Res       Date:  2016-09-30       Impact factor: 12.701

9.  Chk1 and DNA-PK mediate TPEN-induced DNA damage in a ROS dependent manner in human colon cancer cells.

Authors:  Omar Nasser Rahal; Maamoun Fatfat; Carla Hankache; Bassam Osman; Hala Khalife; Khaled Machaca; Hala-Gali Muhtasib
Journal:  Cancer Biol Ther       Date:  2016-10-03       Impact factor: 4.742

10.  Monitoring therapeutic monoclonal antibodies in brain tumor.

Authors:  Rima Ait-Belkacem; Caroline Berenguer; Claude Villard; L'Houcine Ouafik; Dominique Figarella-Branger; Alain Beck; Olivier Chinot; Daniel Lafitte
Journal:  MAbs       Date:  2014       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.